Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649112
Status:
COMPLETED
Last Update Posted:
2022-11-09
First Post:
2020-11-24
Brief Title:
Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies
Sponsor:
Precision BioSciences Inc
Organization:
Precision BioSciences Inc
Study Overview
Official Title:
A Phase 1 Study of PBCAR19B in Participants With CD19-expressing Malignancies
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1 nonrandomized open-label single-dose dose-escalation and dose-expansion study to evaluate the safety and clinical activity of PBCAR19B in adult study participants with CD-19 expressing malignancies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None